During Episode #2440 featuring Matt Damon and Ben Affleck, Joe Rogan discussed BPC-157 Read More Joe Rogan TB-500
For patients with a history of pancreatitis, FDA labeling advises considering other antidiabetic or weight management therapies, though this is not a formal contraindication
Developed by Eli Lilly as a triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, retatrutide achieved a mean body weight reduction of -24.2% at its highest dose over 48 weeks surpassing both semaglutide and tirzepatide in their respective pivotal trials
Factors like dosing, duration, health history, and overall goals matter
Recently, in February 2025, the FDA removed the medications from the shortage list, but they can still be unavailable depending on your location
This can help individuals burn more calories and lose weight more effectively